Atypical Reversible Leucoencephalopathy Syndrome after Bevacizumab/Folfox Regimen for Metastatic Colon Cancer

We are reporting a case of multifocal reversible leucoencephalopathy syndrome induced by chemotherapy based on Folfox-Bevacizumab regimen. A 44-year-old female, with no history of hypertension, received a chemotherapy based on Folfox-Bevacizumab for her metastatic colon cancer (5 FU: 325 mg/m(2) d1...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Case Rep Oncol Med
Hlavní autoři: Salmi, Narimane, Elghissassi, Ibrahim, Bellahammou, Khadija, Lakhdissi, Asmaa, Mrabti, Hind, Errihani, Hassan
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2014
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4221973/
https://ncbi.nlm.nih.gov/pubmed/25400959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/391256
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky